Price target
194.25RUSD+51.82+36.38%
The 28 analysts offering 1 year price forecasts for Biogen Inc. have a max estimate of 342.00 and a min estimate of 135.00.
Analyst rating
Based on 36 analysts giving stock ratings to Biogen Inc. in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
15
Buy
2
Hold
19
Sell
0
Strong sell
0
EPS
Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
0.00
1.50
3.00
4.50
6.00
Reported
Estimate
Currency: USD
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
4.02
4.36
2.95
3.67
5.28
4.08
3.44
—
—
—
—
Estimate
3.78
3.97
3.18
3.47
4.07
3.77
3.33
3.56
4.07
4.08
4.02
Surprise
+6.45%
+9.73%
−7.35%
+5.78%
+29.79%
+8.15%
+3.26%
—
—
—
—
Revenue
Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
0.00
700.00 M
1.40 B
2.10 B
2.80 B
Reported
Estimate
Currency: USD
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
2.46 B
2.53 B
2.39 B
2.29 B
2.46 B
2.47 B
2.45 B
—
—
—
—
Estimate
2.37 B
2.40 B
2.47 B
2.31 B
2.39 B
2.43 B
2.41 B
2.24 B
2.32 B
2.30 B
2.30 B
Surprise
+3.77%
+5.44%
−3.23%
−0.80%
+3.03%
+1.29%
+1.93%
—
—
—
—
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
BIIB EPS for the last quarter is 3.44 USD despite the estimation of 3.33 USD. In the next quarter EPS is expected to reach 3.56 USD. Track more of Biogen Inc. financials and stay on top of what is up with the company.
In the next quarter Biogen Inc. revenue is expected to reach 2.24 B USD. Check out Biogen Inc. revenue and earnings and make informed decisions.
According to analysts, BIIB price target is 194.25 USD with a max estimate of 342.00 USD and a min estimate of 135.00 USD. Check if this forecast comes true in a year, meanwhile watch Biogen Inc. stock price chart and keep track of the current situation with BIIB news and stock market news.
We've gathered opinions of 37 analysts rating BIIB stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.